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Pseudomonas aeruginosa is an opportunistic pathogen that causes life-long pneumonia in individuals with
cystic fibrosis (CF). These long-term infections are maintained by bacterial biofilm formation in the CF lung.
We have recently developed a model of P. aeruginosa biofilm formation on cultured CF airway epithelial cells.
Using this model, we discovered that mutation of a putative magnesium transporter gene, called mgtE, led to
increased cytotoxicity of P. aeruginosa toward epithelial cells. This altered toxicity appeared to be dependent
upon expression of the type III secretion system (T3SS). In this study, we found that mutation of mgtE results
in increased T3SS gene transcription. Through epistasis analyses, we discovered that MgtE influences the
ExsE-ExsC-ExsD-ExsA gene regulatory system of T3SS by either directly or indirectly inhibiting ExsA activity.
While variations in calcium levels modulate T3SS gene expression in P. aeruginosa, we found that addition of
exogenous magnesium did not inhibit T3SS activity. Furthermore, mgtE variants that were defective for
magnesium transport could still complement the cytotoxicity effect. Thus, the magnesium transport function
of MgtE does not fully explain the regulatory effects of MgtE on cytotoxicity. Overall, our results indicate that
MgtE modulates expression of T3SS genes.
Pseudomonas aeruginosa is an opportunistic pathogen that
can cause a wide range of infections in humans (28). One of the
most devastating illnesses that it can produce is chronic infec-
tion in individuals with cystic fibrosis (CF) (14, 39). CF is a
common genetic disorder resulting from mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR), which
is a chloride channel (3, 24). CFTR mutation leads to in-
creased inflammation in the lungs and thickened mucus secre-
tions that plug the airways (3). Within these mucus plugs, P.
aeruginosa can form biofilms that are highly resistant to anti-
biotic killing and immune clearance mechanisms (19, 29, 44).
Growing as a biofilm, P. aeruginosa can persist in the CF lung
for the life of the patient, and this chronic bacterial coloniza-
tion is a major factor leading to morbidity and mortality in
these individuals (39). Strategies aimed at disrupting the for-
mation or maintenance of these biofilms would greatly en-
hance the quality of life for CF patients.
Recent evidence has revealed that P. aeruginosa inversely
regulates biofilm formation and virulence attributes associated
with acute infections (13, 15). One factor that appears to be
regulated in this manner is the type III secretion system
(T3SS), a host cell contact-dependent virulence determinant
involved in host cell toxicity (51). The T3SS is a needle-like
complex with a base structure that spans both the inner and
outer membranes of the bacteria. The tip of this complex can
insert into the cytoplasmic membrane of a host cell, leading to
injection of specific toxin molecules from the bacterial cyto-
plasm directly into the host cell cytoplasm (6, 7).
The central regulatory pathway controlling T3SS gene ex-
pression in P. aeruginosa is carried out by ExsE, ExsC, ExsD,
and ExsA, which modulate the availability of the master acti-
vator ExsA (51) (see Fig. S1 in the supplemental material). All
known inputs that affect T3SS transcription in P. aeruginosa
exert their effects through ExsA, and in the absence of ExsA,
T3SS gene transcription is negligible. Control of ExsA activity
is maintained by alternative sets of complexes, where ExsD
binds and sequesters ExsA (ExsD-ExsA), and ExsC can alter-
natively bind to ExsD or ExsE (ExsC-ExsD or ExsE-ExsC)
(51). ExsE, which sits at the top of this cascade, is exported
through the T3SS apparatus upon EGTA stimulation or mam-
malian cell contact, thus freeing ExsC (11, 51). ExsC then binds
to ExsD (ExsC-ExsD), which in turn liberates ExsA. As such,
mutation of either exsD or exsE hyperactivates T3SS transcrip-
tion by deregulating the Exs network (and freeing ExsA) (50).
On the other hand, mutation of exsC inhibits transcription
because ExsD will bind and sequester ExsA.
Expression of the T3SS during P. aeruginosa infection is asso-
ciated with increased bacterial virulence (39). T3SS is impor-
tant for killing of a variety of eukaryotic cell types, including
epithelial cells, fibroblasts, and macrophages (21, 41). In the
context of CF lung infection, it is thought that the T3SS is
involved in initial tissue destruction and protection from
phagocytes (29). However, over time, the number of T3SS-
expressing P. aeruginosa isolates from an individual CF patient
decreases, likely as the result of mutation of T3SS genes (21,
45). Still, mutation of T3SS genes is not universal, and many
CF isolates retain T3SS functionality (9). In these T3SS-posi-
tive strains, gene expression is likely repressed by regulatory
mechanisms involved in preventing virulence factor production
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during the biofilm mode of growth. Thus, control of T3SS gene
expression appears to be an important factor in the establish-
ment and maintenance of chronic CF lung infection with P.
aeruginosa.
In a recent study describing P. aeruginosa biofilm formation
on cultured human airway epithelial cells, we identified a num-
ber of genes that impact bacterial cytotoxicity toward the cul-
tured cells (1). One of these genes encoded a putative member
of the MgtE family of magnesium transporters. The mgtE gene
was originally discovered during screening of plasmid libraries
in Bacillus firmus as clones that complemented a magnesium
transport-deficient strain (47, 49). Since then, members of the
MgtE transporter family have been identified in Gram-nega-
tive and Gram-positive bacteria, as well as in archaea and
eukaryotes, including humans (23, 30, 40). MgtE family mem-
bers are unique among known magnesium transporters in that
they do not resemble any other protein class or superfamily of
transporters (23, 30). Intriguingly, mutation of mgtE in Campy-
lobacter jejuni and Aeromonas hydrophila leads to defects in
virulence properties, including colonization of host sites, bio-
film formation, and swarming (22, 33). In P. aeruginosa, we
found that mutation of mgtE resulted in increased cytotoxicity
of the biofilms grown on epithelial cells in culture, and it was
discovered that this effect required a functional T3SS (1).
Transcription of T3SS genes was only slightly enhanced in the
mgtE deletion mutant. Mutation of other putative magnesium
transporter genes in P. aeruginosa failed to show a similar
cytotoxic effect, suggesting a specific effect of MgtE on cyto-
toxicity. Importantly, biofilm formation on both epithelial cells
as well as plastic wells remained unaffected by mgtE deletion.
We also found that protease and lipase production in the
mgtE strain appeared to be similar to production in the wild
type (1). Thus, mutating mgtE does not cause a general in-
crease in virulence factor expression.
In this study, we demonstrate that mutation of mgtE leads to
increased T3SS gene expression. We found small but signifi-
cant increases in T3SS gene transcription in the mgtE mutant,
and epistasis analysis with the exsE-exsC-exsD-exsA (exsE-C-
D-A) regulatory cascade genes revealed that mgtE expression
modulates expression of T3SS genes, likely via inhibition of
ExsA-dependent transcription. We also show that regulatory
functions of MgtE in P. aeruginosa can be separated from the
magnesium transport functions of this protein. Thus, it appears
that P. aeruginosa can utilize this membrane protein for two
different roles: magnesium transport and regulation of gene
expression.
MATERIALS AND METHODS
Bacterial strains and plasmids. Bacterial strains and plasmids used in this
study are listed in Table 1. Appropriate antibiotics were used to maintain plasmid
selection (see below). Growth curves were performed in a SpectraMax M2
(Molecular Devices, Sunnyvale, CA). Bacteria were diluted 1/100 in 200 l of
medium with appropriate antibiotics in standard sterile 96-well flat-bottom mi-
crotiter plates, with four wells for each strain. Growth was assayed at 37°C by
measuring the optical density at 600 nm (OD600) every 30 min for 11 h, with
shaking for 5 s before each reading.
Genetic manipulations. (i) Construction of deletion mutants. Isogenic dele-
tion mutants were created as previously described (1, 42). Briefly, gene-flanking
regions were PCR amplified and joined to the suicide vector pMQ30 via homol-
ogous recombination in Saccharomyces cerevisiae. These knockout vectors were
transformed into the cloning strain Escherichia coli S17 and verified by restriction
digest. P. aeruginosa PA14 or PA103 was conjugated with these S17 transfor-
mants, and exconjugants were selected on LB agar with 50 g/ml gentamicin and
20 g/ml nalidixic acid; cells were grown overnight and plated on 10% sucrose
LB agar plates. Mutations were confirmed by PCR and sequencing. Mutation of
mgtE was carried out using plasmid pSMC233 (Table 1). To delete exsA, we
created plasmid pSMC297 using primers ExsALfor, ExsALrev, ExsARfor, and
ExsARrev, and primers ExsAfor and ExsArev were used to confirm mutation
(Table 2). To delete exsC, we created plasmid pSMC298 using primers ExsCLfor,
ExsCLrev, ExsCRfor, and ExsCRrev, and primers ExsCfor and ExsCrev were
used to confirm mutation. To delete exsD, we created plasmid pSMC296 using
primers ExsDLfor, ExsDLrev1, ExsDRfor1, and ExsDRrev, and primers
ExsDfor and ExsDrev were used to confirm mutation. To delete exsE, we
created plasmid pSMC299 using primers ExsELfor, ExsELrev, ExsERfor, and
ExsERrev, and primers ExsEfor and ExsErev were used to confirm mutation.
(ii) Creation of complementing plasmids. To create a plasmid carrying mgtE,
we PCR amplified mgtE from strain PA14 using primers 913forRBS (EcoRI site)
and 913revHindIII (HindIII site) (Table 2). This fragment was ligated into
EcoRI/HindIII-digested pMQ70, creating pSMC291. To create pSMC292 (C-
terminally six-histidine tagged mgtE), we PCR amplified mgtE from PA14 using
primers 913forRBS (EcoRI site) and 913revHindHIS (HindIII site). This frag-
ment was ligated into EcoRI/HindIII-digested pMQ70. Plasmid pSMC293 (N-
terminally six-histidine tagged mgtE) was created by PCR amplification of mgtE
from pSMC291 using primers MgtNHISfor and 913Nrightrev. This fragment was
then joined with HindIII-digested pMQ70 via homologous recombination in
S. cerevisiae, as described previously (42). Plasmid pSMC295 (mgtE with
mutations in Mg2 binding sites 2 and 3) was created by PCR amplification
of mgtE from pSMC293 in two pieces using primer pairs R-Pbad–MgSite2/
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Relevant genotype ordescription
Reference or
source
P. aeruginosa strains
PA14 Wild type 38
PA103 Wild type 27
SMC3604 PA14 mgtE 1
SMC4333 PA14 exsA This study
SMC4331 PA14 exsC This study
SMC4335 PA14 exsE This study
SMC4334 PA14 mgtE exsA This study
SMC4332 PA14 mgtE exsC This study
SMC4336 PA14 exsE exsD This study
SMC4404 PA103 mgtE This study
SMC4405 PA14:PexsD-lacZ This study
SMC4406 SMC3604:PexsD-lacZ This study
SMC4407 PA103:PexsD-lacZ 31
SMC4408 SMC4404: PexsD-lacZ This study
E. coli strain
S17-1 Laboratory strain for cloning 43
S. cerevisiae strain
InvSc1 In vivo cloning; ura3-52/ura3-52 Invitrogen
S. Typhimurium strain
MM281 corA45::MudJ mgtA21::MudJ
mgtB10::MudJ
Salmonella Genetic
Stock Centre
Plasmids
pMQ30 Allelic replacement vector;
yeast cloning
42
pMQ70 PBAD expression vector 42
pSMC233 Deletion of mgtE; pMQ30
backbone
1
pSMC297 Deletion of exsA This study
pSMC298 Deletion of exsC This study
pSMC296 Deletion of exsD This study
pSMC299 Deletion of exsE This study
pSMC291 pMQ70-mgtE This study
pSMC292 pMQ70-mgtE-C-His This study
pSMC293 pMQ70-mgtE-N-His This study
pSMC295 pMQ70-mgtE-BS2/3
(Mg2 binding sites 2 and 3
changed to alanine)
This study
Mini-CTX-PexsD-lacZ lacZ expression from exsD
promoter
31
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3Left and MgSite2/3Right-913Nrightrev. MgSite2/3Left and MgSite2/3Right
contained base changes relative to wild-type mgtE sequence such that glu-
tamines encoded at amino acid positions 289 and 293 were changed to
alanines, and serine 292 was changed to alanine. These PCR fragments were
joined with HindIII-digested pMQ70 via homologous recombination in S.
cerevisiae.
Cell culture. For bacterial-epithelial cell coculture, we used CFBE41o pa-
rental (CFBE) cells, which are immortalized human CF-derived airway epithelial
cells (4, 8, 48). CFBE cells were maintained in minimal essential medium (MEM)
(10-010-CV; Mediatech, Manassas, VA) supplemented with 10% fetal bovine
serum, 2 mM glutamine, 50 U/ml penicillin, and 50 g/ml streptomycin. Cells
were incubated at 37°C in 5% CO2 and fed fresh medium every 2 to 3 days.
Cytotoxicity assays. Cytotoxicity was assessed using the CytoTox96 Nonradio-
active Cytotoxicity Assay kit (TB163; Promega, Madison, WI). CFBE cells were
seeded at 2  105 cells per well in 24-well tissue culture plates with 0.5 ml of
MEM, and these cells were grown for 7 to 10 days at 37°C in 5% CO2 before use.
Medium was replaced every 2 to 3 days. Confluent epithelial monolayers were
inoculated with bacteria at 2 107 CFU/ml in each well (multiplicity of infection
[MOI] of 30:1), as previously described (1). Fresh MEM (0.5 ml) with 0.4%
arginine was added at 1 h postinoculation, and the sample was incubated for an
additional 5 h at 37°C in 5% CO2. After this incubation, 400 l of the superna-
tant was harvested, and cytotoxicity was assessed according to the manufacturer’s
instructions, as previously described (1). In experiments testing wild-type and
mutant strains, bacteria were concurrently inoculated into separate wells, and
supernatants were collected at the same time points (6 h postinoculation). Pre-
vious experiments have shown that this method results in an equal number of
CFU of wild-type and mgtE strains attached to the epithelial cells (1). As a
positive control for the cytotoxicity assays, we added 1% Triton X-100 to a
separate set of wells containing uninoculated CFBE cell monolayers. This re-
sulted in a complete lysis of the epithelial cells. This control provided a measure
of 100% cytotoxicity because it represents a maximum release of lactate dehy-
drogenase (LDH) from these cells. A value of 0% cytotoxicity represents the
average value of the supernatant from a separate set of uninoculated wells in the
absence of Triton X-100. This control provides a measure of the spontaneous
release of LDH from the CFBE cells, and values were normalized to this level.
Percent cytotoxicity was determined by the following calculation: 100  (exper-
imental value  spontaneous release value)/maximum release. We performed
each assay in triplicate, and presented data are representative of at least three
experiments.
Transcriptional assays. (i) qRT-PCR. Transcriptional levels of T3SS genes
in CFBE-P. aeruginosa coculture were determined by quantitative real-time
PCR (qRT-PCR), as previously described (1, 26). We used primer pairs
PA1713F-PA1713R (exsA), ExoURTfor-ExoURTrev, PopNRTfor-PopNRTrev,
and 1693for-1693rev (pscR) (Table 2). Expression values for each sample were
normalized to fbp transcript levels (PA5110for-PA5110rev), which remain con-
stant regardless of experimental conditions (1, 26).
TABLE 2. Primers used in this study
Primer Sequence (5–3)
913forRBS..................................................AAGAATTCAGGAGGAGCGCGCTATGACCGAAGTAG
913revHindIII ............................................AAAAGCTTGCTACATCAGGAAGATCGTC
913revHindHIS..........................................AAAAGCTTGCTAATGATGATGATGATGATGCATCAGGAAGATCGTC
MgtNHISfor...............................................CGTTTTTTTGGGCTAGCGAATTCAGGAGGAGCGCGCTATGCATCATCATCATCATCATACC
GAAGTAGAAGCCAAGAAG
913Nrightrev ..............................................CAGACCGCTTCTGCGTTCTG
MgSite2/3Left ............................................ACCGGCCATGTTGAGGACCGCCGCTTCGCTCGCCTCACGGATCAG
MgSite2/3Right ..........................................CTGATCCGTGAGGCGAGCGAAGCGGCGGTCCTCAACATGGCCGGT
F-t1t2...........................................................CAGACCGCTTCTGCGTTCTG
R-Pbad........................................................GCAACTCTCTACTGTTTCTCC
PA1713F.....................................................GCTGATGCTCTTCGCGTTCAGTCC
PA1713R ....................................................TGGGCATAGAGGATTCTCCGCTCG
ExoURTfor ................................................AATTGCGCGAGCAAACCGTTG
ExoURTrev................................................TTCTGTTGAGCAACACTGGTGAGC
PopNRTfor ................................................ATGGACATCCTCCAGAGTTCCTC
PopNRTrev ................................................TGCAGCATGGCCTGGACTTC
1693for ........................................................ATGATCCAGTTGCCCGACGAG
1693rev........................................................TCACGTACAGGCTGAGGATG
PA5110for ..................................................CCTACCTGTTGGTCTTCGACCCG
PA5110rev ..................................................GCTGATGTTGTCGTGGGTGAGG
ExsALfor ....................................................TCGACTGAGCCTTTCGTTTTATTTGATGCCTGGCAGTTCCAGGGTTTGAGCGGTTCCATG
ExsALrev....................................................CGATTCTACTCATGCAGCCGCCCAACACTTCCCGTCGTAC
ExsARfor....................................................GTACGACGGGAAGTGTTGGGCGGCTGCATGAGTAGAATCG
ExsARrev ...................................................GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTGATCCATGATTCCTCGGTAG
ExsAfor.......................................................TGCAAGTCTCGTTCGTTGTC
ExsArev ......................................................CGGGAGTACTGCTTATCGTC
ExsCLfor ....................................................TCGACTGAGCCTTTCGTTTTATTTGATGCCTGGCAGTTCCGCGATCTGAGGAGACGTCAC
ExsCLrev ....................................................GATTTTCATGGAACCGCTCACTTGCTCGTTAAATCCATGG
ExsCRfor ....................................................CCATGGATTTAACGAGCAAGTGAGCGGTTCCATGAAAATC
ExsCRrev....................................................GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTCTGATTCGCAGAGCGAGTCG
ExsCfor .......................................................AAGGTCGAGGACCAGATGAG
ExsCrev.......................................................GCTCGGCAATCGTTTGCATC
ExsDLfor ....................................................TCGACTGAGCCTTTCGTTTTATTTGATGCCTGGCAGTTCCTCAAGGTACGACGGGAAGTG
ExsDLrev1..................................................CTCAGCTCTGCCAGTAGAAGTCTCTGCCTTGGCTTCCTCAC
ExsDRfor1..................................................GTGAGGAAGCCAAGGCAGAGACTTCTACTGGCAGAGCTGAG
ExsDRrev ...................................................GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTTACTCGATCTTGCGGTCCTC
ExsDfor.......................................................GCGACATGAGCATCGTCGAC
ExsDrev ......................................................CAGCAACAGGACGCTCTGTC
ExsELfor ....................................................TCGACTGAGCCTTTCGTTTTATTTGATGCCTGGCAGTTCCAGGAGAAGACCCTGCAGAAG
ExsELrev ....................................................CAACAGCATCCAGCACCTCAGGAACCGCTCAAACCCTCATG
ExsERfor ....................................................CATGAGGGTTTGAGCGGTTCCTGAGGTGCTGGATGCTGTTG
ExsERrev....................................................GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTAACGCTCGACTTCGCTCAAC
ExsEfor .......................................................TGCTGTTCGACGAACAGGTG
ExsErev.......................................................ATCGTTTGCATCCCTCCCTG
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(ii) -Galactosidase assays. The PexsD-lacZ reporter strains were created using
the mini-CTX-PexsD-lacZ construct, and -galactosidase assays for planktonically
grown cells were performed as previously reported (11, 31). T3SS was stimulated
by chelation of calcium with 1 mM EGTA. To test the effect of magnesium on
T3SS transcription, we added 20 mM MgCl2. The reported values are the aver-
age of three independent experiments. -Galactosidase assays in coculture bio-
films were performed as above, with slight modifications. After a 6-h develop-
ment of coculture biofilms, six replicate wells of each strain were washed two
times with 1 ml of phosphate-buffered saline (PBS). Three wells were harvested
in 1 ml of 0.1% Triton X-100 in PBS and plated for CFU determination. Three
wells were harvested in 0.5 ml of 0.1% Triton X-100 in PBS for -galactosidase
activity. To this second set of samples, we added 0.5 ml of Z buffer (16.1 g/liter
Na2HPO4  7H2O, 5.5 g/liter NaH2PO4  4H2O, 0.75 g/liter KCl, 0.246 g/liter
mgSO4  7H2O, 2.7 ml -mercaptoethanol [pH 7.0]), 40 l of chloroform, and 10
l of 0.1% SDS. This solution was vortexed for 10 s and incubated at 30°C for 5
min. A total of 200 l of 4 mg/ml o-nitrophenyl--D-galactopyranoside (ONPG)
was added for 90 min at 30°C, and then 0.5 ml of 1 M Na2CO3 was added to stop
the reaction. PexsD-lacZ expression was determined by the following calculation:
{[OD420  (1.75  OD550)]/number of CFU}  109. This calculation represents
a modification of the standard Miller unit equation in that data were normalized
to the number of CFU rather than OD600 value of the bacteria due to difficulty
in taking optical density measurements specifically of the bacteria in coculture
experiments. Thus, on graphs displaying results from these experiments, we have
labeled the y axis PexsD-lacZ expression rather than Miller units. Three replicate
wells containing only CFBE cells were similarly processed, and OD420 and OD550
values for these CFBE-only samples were subtracted from the respective sample
values above as a baseline. Data are representative of three independent exper-
iments.
Western immunoblotting. For Western blotting of membrane fractions, bac-
terial cultures were grown overnight, and bacteria (1.2 ml of overnight culture)
were resuspended in 200 mM Tris-HCl (pH 7.5), 20 mM EDTA, and 1 pro-
tease inhibitors and lysed on ice by six 10-s bursts with a tip sonicator (Vibra-Cell,
Sonics and Materials, Inc., Newtown, CT) set at 30% power. Unlysed bacteria
were removed by brief centrifugation in a microcentrifuge, and 1.1 ml of super-
natant was centrifuged at 100,000  g at 4°C for 1 h to pellet membranes.
Membrane pellets were resuspended in 1 ml of 20 mM Tris-HCl, pH 7.6.
Supernatant fractions were prepared by sedimenting 1 109 cells (centrifugation
for 4 min at 12,500  g at 4°C) and then transferring 1 ml of the cell-free
supernatant to a fresh tube containing 350 l of 50% trichloroacetic acid. Sam-
ples were incubated on ice for 30 min, and precipitated proteins were collected
by centrifugation (15 min at 12,500  g at 4°C), washed with acetone, and
suspended in SDS-PAGE sample buffer. Western blotting was carried out ac-
cording to standard molecular biology protocols using anti-histidine (Qiagen,
Valencia, CA), anti-ExoU, and anti-PcrV primary antibodies and goat anti-
rabbit or anti-mouse IgG-horseradish peroxidase (HRP) secondary antibodies
(Bio-Rad, Hercules, CA). We used Western Lightning Chemiluminescence Re-
agent Plus (Perkin Elmer, Boston, MA). Detection of SadB and SecY was
performed as cytoplasmic and membrane fraction controls (5, 34). The presence
of nonspecific bands in SadB lanes (see Fig. 7) as well as the apparent cytoplas-
mic presence of SecY has been reported previously (5, 34).
Salmonella magnesium bioassay. Magnesium transport was assessed indirectly
using Salmonella enterica serovar Typhimurium MM281, as previously described
(47, 49). This strain contains mutations in all of its known magnesium transport-
ers and thus will not grow without supplementation with 100 mM magnesium.
Growth of this strain in minimal medium without added magnesium requires the
bacterium to be transformed with a plasmid containing a magnesium transporter
gene. This assay has been used as a surrogate for magnesium uptake assays by
serving as a sensitive test for functional complementation of the deficient mag-
nesium transport in MM281 (47, 49). Thus, the ability of MgtE and derivative
constructs to transport magnesium was determined by electroporating MM281
with plasmid pmgtE, pmgtE with a C-terminal His tag (pmgtE-C-His, or pCHIS),
pmgtE with an N-terminal His tag (pmgtE-N-His, or pNHIS), or pBS2/3 (Table
1). Transformants were selected on LB plates supplemented with 100 mM
MgSO4 and 50 g/ml carbenicillin (to maintain plasmid selection), and proper
transformation was confirmed by plasmid isolation and restriction digest. These
clones were then grown overnight at 37°C in LB medium with 100 mM MgSO4
and 50 g/ml carbenicillin, and 20 l of this culture was streaked out on N
minimal medium agar plates [5 mM KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4,
1 mM KH2PO4, 0.1 M Tris-HCl, 0.1% Casamino Acids, 38 mM glycerol](35).
The ability to transport magnesium was assessed as growth overnight on N plates
at 37°C.
Statistical analysis. Statistical significance was determined as a P value of
	0.05 using a Student’s t test.
RESULTS
MgtE affects T3SS gene expression. Recent studies have
found that P. aeruginosa forms biofilms upon cultured airway
epithelial cells within 6 to 8 h after inoculation (1). Using this
biofilm coculture system, we discovered that deletion of the
mgtE gene resulted in increased cytotoxicity of P. aeruginosa
biofilms grown on cultured CFBE cells (1). Because this in-
creased cytotoxicity required a functional T3SS, we reasoned
that the mgtE deletion mutant might exhibit increased secre-
tion of effector molecules through the T3SS apparatus. To test
this hypothesis, we performed Western immunoblotting on
bacterial supernatants prepared from planktonic bacteria
grown in the presence or absence of EGTA to chelate extra-
cellular calcium. Low-calcium conditions are known to stimu-
late type III secretory activity, which then results in an increase
in T3SS gene expression. Supernatant fractions were probed
for the T3SS-secreted proteins ExoU and PcrV (12, 51). As
expected, EGTA treatment resulted in greater amounts of
ExoU and PcrV in the supernatant fraction (Fig. 1A). In ad-
dition, we found an increase in both ExoU and PcrV in super-
natants of the mgtE mutant compared to wild-type P. aerugi-
nosa strain PA14 (Fig. 1A). Quantification of band intensity
revealed this increase to be approximately 2-fold. Similar to
results for PA14, we found an approximate 2-fold increase in
the amount of ExoU and PcrV secreted into the supernatant in
planktonic cultures of the mgtE mutant compared to wild-
type PA103 (see Fig. S2A in the supplemental material).
These data suggest that one activity of MgtE might be to
inhibit T3SS gene expression. In support of this hypothesis, we
grew CFBE-P. aeruginosa coculture biofilms of wild-type PA14
transformed with a multicopy plasmid carrying mgtE (PA14
pmgtE), and we monitored cytotoxicity toward the CFBE cells.
We discovered a significant decrease in the cytotoxicity of
PA14 pmgtE compared to PA14 carrying a vector control (Fig.
1B). We also tested gene expression of T3SS by qRT-PCR in
biofilms of these same strains grown on epithelial cells. As
expected, we found significantly decreased transcript levels of
FIG. 1. Mutation of mgtE leads to increased effector molecule se-
cretion through T3SS. (A) Western immunoblotting of supernatants
from planktonic cultures of strain PA14 (WT) and its isogenic mgtE
deletion mutant. Supernatants were probed with antibodies to ExoU
and PcrV in the presence and absence of the calcium chelator EGTA.
(B) Cytotoxicity of wild-type PA14 (WT), with vector control (p70,
or pMQ70) plasmid or with a plasmid carrying mgtE (pmgtE, or
pSMC291), toward CFBE cells at 6 h postinoculation. The value of
100% cytotoxicity represents a maximum release from the CFBE cells
by Triton X-100 lysis. *, P 	 0.05. (C) Relative exsA expression by
qRT-PCR in 6-h coculture biofilms formed by the wild type (WT) with
vector control (p70) or the wild type expressing mgtE from plasmid
pmgtE. fbp transcript levels were used as a normalization control. *,
P 	 0.05.
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the T3SS gene exsA in the wild-type strain carrying mgtE on a
plasmid compared to vector control (Fig. 1C). Thus, mgtE
expression inhibits bacterial cytotoxicity, and this effect most
likely occurs through inhibition of T3SS gene expression.
Mutation of mgtE leads to small but significant increases in
T3SS gene transcription. In our previous study, we used qRT-
PCR to investigate transcriptional activity of T3SS genes in
wild-type PA14 and a mgtE strain (1). While we saw no
change in pcrV or exoT transcript levels between wild-type
PA14 and the mgtE strain at the time point that we examined,
we did find a small but significant increase in expression of
pcrH in the mgtE mutant. These results suggested that mu-
tation of mgtE might lead to small changes in T3SS gene
transcription. To explore this effect further, we assayed exsA
transcript levels by qRT-PCR in CFBE coculture biofilms
formed by either wild-type or mgtE mutant strains. In con-
trast to the inhibition of exsA transcription seen by overex-
pressing mgtE in wild-type P. aeruginosa (Fig. 1C), we observed
a significant increase (P 	 0.05) in relative exsA expression in
the mgtE strain over the wild-type strain (Fig. 2A). Combin-
ing data from multiple experiments, we also observed a signif-
icant increase in relative exoU transcript levels in the mgtE
strain (data not shown) although occasionally we found no
difference between wild-type and mgtE strains in individual
experiments (see below and Fig. S3 in the supplemental ma-
terial). We further assayed T3SS gene expression in these
strains using a chromosomally integrated construct that ex-
presses the lacZ gene from the exsD promoter (PexsD-lacZ) (see
Materials and Methods). exsD is the first gene in the exsD-pscL
operon, and the PexsD-lacZ construct has been used to monitor
activation of T3SS gene transcription (11). Wild-type and
mgtE strains were grown as biofilms in coculture with CFBE
cells, and PexsD-lacZ activity was determined as described in
Materials and Methods (providing a relative PexsD-lacZ expres-
sion activity rather than Miller units). This experiment also
revealed a significantly greater T3SS promoter activity in the
mgtE strain than in the wild type (Fig. 2B). In planktonic, broth-
grown cultures stimulated with EGTA, the mgtE strain carrying
the PexsD-lacZ reporter exhibited a similar trend toward increased
-galactosidase activity over the wild-type strain although this
effect was not significant (Fig. 2C).
As mentioned above, T3SS gene expression is induced under
low-calcium conditions due to a stimulation of ExsA-mediated
gene transcription (12, 51). MgtE has been described as a
magnesium transporter in several microorganisms, and it is
formally possible that the P. aeruginosa mgtE mutant has re-
duced intracellular magnesium levels that similarly affect T3SS
gene expression. Because magnesium, when present in high
concentrations, has been shown to diffuse across bacterial
membranes in the absence of transporters (45, 46), we rea-
soned that supplementation with magnesium might overcome
any potential magnesium transport deficiency and inhibit T3SS
gene expression. To test this hypothesis, wild-type and mgtE
strains carrying the PexsD-lacZ reporter were cultured in me-
dium containing 20 mM MgCl2 in the presence or absence of
EGTA and then assayed for -galactosidase activity. In the
absence of EGTA, PexsD-lacZ reporter activity in wild-type
PA14 was similar to that of the mgtE strain regardless of
magnesium (Fig. 2C). Intriguingly, EGTA-dependent expres-
sion of the PexsD-lacZ reporter was slightly increased (	2-fold)
for both the wild-type and mgtE strains when cells were
grown in the presence of magnesium (Fig. 2C). -Galactosi-
dase activity was also significantly enhanced in the mgtE
strain versus the wild type under magnesium stimulation.
We also tested T3SS activity in P. aeruginosa strain PA103,
which displays a much higher level of T3SS transcription and
secretion than strain PA14 (25, 36). We reasoned that this
relative increase in T3SS gene expression might accentuate any
differences in T3SS transcription between wild-type PA103 and
mgtE. Using the PexsD-lacZ construct in PA103 and its isogenic
mgtE strain, we found a significant increase (2-fold) in
-galactosidase activity in planktonic cultures of the mgtE
strain under both high- and low-calcium conditions compared
with levels in wild-type PA103 (see Fig. S2B in the supple-
mental material). These data correlate well with the 2-fold
increase in secretion and transcription seen with the PA14
mgtE strain, as shown above (Fig. 1A and 2B). Culturing
PA103 and its isogenic mgtE strain in the presence of 20
mM MgCl2 resulted in no differences between magnesium-
treated versus untreated samples although we did observe a
FIG. 2. Mutation of mgtE results in small increases in T3SS tran-
scription. (A) Transcription of T3SS was measured as exsA transcript
levels by qRT-PCR in wild-type PA14 (WT) and the mgtE strain
grown as biofilms in coculture with CFBE cells. The y axis measures
relative exsA transcript levels, using fbp transcript levels as a normal-
ization control (see Materials and Methods). Data represent the av-
erage of three independent experiments, each containing triplicate or
quadruplicate samples. Each of these samples was assayed in triplicate
by qRT-PCR. *, P 	 0.05. (B) -Galactosidase activity was measured
from the PexsD-lacZ construct in wild-type PA14 (WT) and the mgtE
strain grown as biofilms in coculture with CFBE cells. The y axis
represents relative -galactosidase activity from the PexsD-lacZ tran-
scriptional fusion construct, normalized to the number of CFU (see
Materials and Methods). Data are representative of three independent
experiments. *, P	 0.05. (C) Transcription of T3SS was also measured
in broth cultures as -galactosidase activity (Miller units) using the
PexsD-lacZ fusion construct in wild-type PA14 (WT) and the isogenic
mgtE deletion mutant. Transcriptional activity was assessed in the
presence and absence of 1 mM EGTA, as indicated. Replicate samples
were additionally treated with 20 mM MgCl2, as indicated. *, P	 0.05,
compared to EGTA-stimulated WT cells without magnesium; #, P 	
0.05, compared to EGTA-stimulated mgtE cells without magnesium;
†, P 	 0.05 compared to EGTA-stimulated WT cells with magnesium.
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significant increase in mgtE samples versus wild-type sam-
ples (see Fig. S2B). Thus, although this effect is small, it is
clear that mutation of mgtE increases T3SS gene transcrip-
tion. This consequence appears to be independent of mag-
nesium levels (see below).
MgtE influences the ExsE-C-D-A regulatory cascade. As
mentioned above, transcriptional regulation of T3SS gene ex-
pression relies on the availability of the master activator pro-
tein ExsA. We deleted exsA in PA14 and in the mgtE back-
ground (see Fig. S1B in the supplemental material) and tested
for cytotoxicity toward CFBE cells. As expected, the exsA
mutant exhibited very little cytotoxicity toward the epithelial
cells (Fig. 3). We also found that the mgtE exsA double
mutant had very little cytotoxicity. This result demonstrates
that mgtE requires ExsA-mediated transcriptional activation
to achieve increased toxicity toward cultured cells, a result that
is consistent with our previous data showing that mgtE muta-
tion requires a functional T3SS (1). This experiment is also
consistent with our hypothesis that MgtE affects T3SS tran-
scription.
To investigate the transcriptional effects of MgtE on T3SS
gene expression further, we performed an epistasis analysis
between mgtE and the exs regulatory genes. As mentioned
above, control of ExsA activity is maintained by alternate sets
of complexes formed by the ExsE, ExsD, ExsC, and ExsA
proteins. Mutation of the exs genes affects the availability of
ExsA and, thus, the transcriptional state of T3SS genes. We
first deleted exsC in the wild type as well as the mgtE back-
ground. As expected, the exsC mutant showed very little cyto-
toxicity (Fig. 4A). In this situation, ExsD is free to bind to
ExsA, which would inhibit T3SS transcription (see Fig. S1C in
the supplemental material). When we tested the mgtE exsC
double mutant, we found that this strain also exhibited very
little cytotoxicity (Fig. 4A). We also examined transcript levels
of exsA in coculture biofilms by qRT-PCR in these same back-
grounds; exsA is autoregulatory. We found 3-fold lower rel-
ative levels of exsA transcription in both the exsC and mgtE
exsC strains than in the wild-type and mgtE strains (Fig. 4B).
Similar patterns were also observed when we assayed transcript
levels of pscR, popN, and exoU (see Fig. S3A to C), which all
map to different T3SS operons. These data support the hy-
pothesis that MgtE-mediated T3SS inhibition functions via
ExsC although it is still possible that MgtE acts directly on
ExsA (see below).
We next deleted exsE in PA14, which has the predicted effect
of dramatically increasing T3SS activation (see Fig. S1D in the
supplemental material). In fact, we observed nearly 100% cy-
totoxicity toward CFBE cells at the time point we investigated
(Fig. 4C). We decided to complement the exsE strain with
FIG. 3. Cytotoxicity effects of MgtE require ExsA-mediated gene
transcription. Wild-type PA14 (WT), the mgtE deletion mutant, the
exsA deletion mutant, and the double deletion strain mgtE exsA
were tested for cytotoxicity toward CFBE cells at 6 h. The value of
100% cytotoxicity represents a maximum release from the CFBE cells
by Triton X-100 lysis. *, P 	 0.05, compared to the mgtE mutant.
FIG. 4. MgtE expression impacts the Exs regulatory system. Cytotoxicity assays (A, C, and E) and expression levels of exsA (B, D, and F) were
examined in the exsC mutant and the mgtE exsC double mutant (A and B), the exsE mutant complemented with vector control (p70) or pmgtE
(C and D), and the exsED double mutant complemented with vector control or pmgtE (E and F). Results were compared to wild-type PA14 (WT)
and the isogenic mgtE deletion mutant. Relative exsA expression was determined by qRT-PCR of coculture biofilms at 6 h postinoculation, as
described in Materials and Methods. A value of 100% cytotoxicity represents a maximum release from the CFBE cells by Triton X-100 lysis. *,
P	 0.05, compared to WT and mgtE strains (A and B), exsE p70 (C), exsED p70 (E), and WT p70 and mgtE p70 (D and F); #, P	 0.05, compared
to exsE p70 (D) or exsED p70 (F).
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plasmid pmgtE to determine whether mgtE expression can
override the hyperactivated Exs cascade to inhibit cytotoxicity,
similar to the effect of mgtE expression in wild-type PA14 (Fig.
1B). We found that complementation with pmgtE severely
abrogated cytotoxicity in the exsE strain (Fig. 4C).
While it is likely that MgtE is inhibiting transcription of
T3SS genes, the above data are also consistent with the hy-
pothesis that expression of MgtE might instead inhibit secre-
tion of T3SS exoproteins, possibly as the result of interaction
with the T3SS structure. In other words, MgtE might be di-
rectly or indirectly blocking the secretion pore. If this hypoth-
esis is correct, then expression of mgtE in the exsE strain
would result in decreased cytotoxicity (because of decreased
secretion of T3SS exotoxins) while transcription of T3SS genes
should be unaffected compared to the exsE strain without
pmgtE. However, it is also possible that MgtE production spe-
cifically affects T3SS transcription rather than secretion. In this
scenario, both cytotoxicity and transcription should be de-
creased by expression of mgtE in the exsE strain. To test these
hypotheses, we performed qRT-PCR on exsA, pscR, popN, and
exoU (Fig. 4D; see also Fig. S3D to F in the supplemental
material). As shown, transcription of T3SS genes is dramati-
cally lower in the exsE strain complemented with pmgtE than
in the vector control, which is consistent with the hypothesis
that MgtE inhibits T3SS gene transcription. Thus, our data
suggest that MgtE inhibits cytotoxicity by decreasing T3SS
gene transcription rather than by blocking the secretion pore.
The above data suggest that MgtE acts through either ExsC
or ExsA to impact T3SS gene expression. To differentiate
between these possibilities, we constructed the double deletion
mutant strain exsE exsD, which is predicted to display an
increased cytotoxicity phenotype due to release of ExsD-me-
diated inhibition of ExsA (see Fig. S1E). We favored this
double mutant over the single exsD construct because we felt
it was important to examine T3SS transcription in the absence
of any Exs inhibitory protein. If MgtE acts at the level of ExsC,
then we would expect that complementation of the exsE
exsD mutant with pmgtE would have no effect on cytotoxicity
or transcription because ExsA would still be free to bind to
T3SS promoters and activate transcription. Intriguingly, we
found that complementation of this double mutant with pmgtE
abrogated cytotoxicity (Fig. 4E) as well as T3SS gene transcrip-
tion (Fig. 4F). Thus, MgtE appears to act directly or indirectly
on ExsA.
Western blotting using exsE and exsED mutant bacteria
grown in broth cultures showed further that complementation
with pmgtE resulted in decreased levels of ExoU and PcrV
secreted into the supernatant compared to levels with the vec-
tor control (Fig. 5). The wild type complemented with pmgtE
also exhibited decreased PcrV secretion, but, unexpectedly,
ExoU levels changed little or perhaps increased slightly. This
result suggests that there is some physiological difference in
MgtE-mediated T3SS triggering between EGTA-stimulated
planktonic bacteria and coculture biofilms, the basis of which
we do not fully understand at this time. While it is also unclear
why there appeared to be more secretion in the exsE strain
than in the exsED mutant, it is important to note that expres-
sion of mgtE led to diminished ExoU and PcrV secretion in
both strains.
Separation of cytotoxicity and magnesium transport func-
tions. Considering that magnesium is not known to alter T3SS
activity and considering our previous observations that muta-
tion of other magnesium transporters does not affect cytotox-
icity (1), the data presented above (Fig. 2; see also Fig. S2 in
the supplemental material) support the hypothesis that mag-
nesium treatment does not inhibit T3SS activity. If the regu-
latory effects of MgtE on cytotoxicity are different than the
magnesium transport functions, then it should be possible to
separate these functions. This is an important question because
of our data in Fig. 2 showing no role for increased magnesium
concentration in MgtE-mediated inhibition of T3SS transcrip-
tion. We felt that this observation made it necessary to explic-
itly address whether magnesium uptake, or another function of
MgtE, is important for the observed phenotypes caused by the
mgtE mutation. Toward this end, we explored whether it was
possible to create mgtE mutants that could complement cyto-
toxicity (as performed above) but that were defective with
respect to magnesium transport.
To assay for magnesium transport, we used S. enterica sero-
var Typhimurium MM281 because this strain contains muta-
tions in all of its known magnesium transport genes, and it
requires supplementation with 100 mM magnesium in order to
grow in minimal medium (46, 49). This strain is a tool that has
been used to identify magnesium transporters by transforma-
tion with plasmids containing putative magnesium transport
genes (46, 49). If the gene encodes a viable magnesium trans-
porter, the strain will grow on minimal medium plates without
added magnesium, whereas strains with an empty vector will
not grow. Importantly, when we transformed MM281 with a
plasmid carrying mgtE (pmgtE), we observed growth on mini-
mal medium plates while MM281 with empty vector (p70) did
not grow (Fig. 6A).
In order to create mgtE mutations with altered magnesium
transport capabilities, we first added a six-histidine epitope tag
to the C terminus of MgtE (see Materials and Methods) so that
we could use Western immunoblotting to monitor whether our
mgtE mutants were stably expressed. After transformation into
MM281, we discovered that this pmgtE-C-His (pCHIS) con-
struct failed to support growth on minimal medium plates (Fig.
6A). This effect might be due to the fact that His6 tags bind to
metals quite readily, and perhaps our tag is binding to magne-
sium and preventing transport. Furthermore, the His6 tag that
FIG. 5. pmgtE inhibits ExoU and PcrV secretion. Western blots of
supernatants from wild-type (WT), exsE, and exsED strains grown
planktonically and complemented with empty vector (pMQ70) or
pmgtE. Cultures were grown in broth and treated with 1 mM EGTA to
stimulate T3SS, as described in Materials and Methods.
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we added appears to be positioned directly over the periplas-
mic opening of the magnesium pore of MgtE, as predicted by
the recent crystal structure of MgtE from Thermus thermophi-
lus (18). Intriguingly, we found that the pCHIS construct fully
complemented the cytotoxicity phenotype of the mgtE strain
(Fig. 6B). Thus, by simply adding a His6 tag to the C terminus
of MgtE, we demonstrated that the magnesium transport and
cytotoxicity functions of MgtE could be separated.
To resolve the transport issues associated with the C-
terminal His tag, we created an N-terminally His6-tagged
MgtE (pNHIS). This construct complemented both magne-
sium transport and cytotoxicity (Fig. 6A and B). These data
support the hypothesis that the regulatory effects of MgtE
on cytotoxicity are independent of the magnesium transport
functions of MgtE.
However, it is possible that pCHIS permits a small amount
of magnesium to be transported, and this very small amount
might be enough to affect T3SS gene expression. We tested this
hypothesis by performing minimal medium growth curves of
MM281 complemented with the vector control, pmgtE, pCHIS,
or pNHIS. We found that pNHIS permitted robust growth of
MM281 while MM281 pCHIS did not grow at all and was
similar to the strain carrying the vector control (see Fig. S4 in
the supplemental material). MM281 strains carrying the untagged
mgtE on a plasmid or expressing the N-terminally tagged variant
grew equally well. These data indicate that the pCHIS construct
of MgtE is nonfunctional for magnesium transport.
The above results encouraged us to look for point mutants
of mgtE that could still inhibit cytotoxicity but could no longer
transport magnesium. Using the pNHIS plasmid as a back-
ground, we mutated glutamine at position 289, serine at 292,
and glutamine at 293 to alanines (E289A, S292A, and E293A,
respectively). These three residues form two different pre-
dicted binding magnesium binding sites in MgtE (18). MgtE is
predicted to contain six magnesium binding sites that appear to
be important for effecting proper subunit positioning during
conformational changes that occur as the magnesium pore
opens and closes (20). The E289A/S292A/E293A mutations
affected amino acid residues in predicted binding sites 2 and 3.
This plasmid construct (pBS2/3) failed to complement magne-
sium transport in S. Typhimurium (Fig. 7A) but fully comple-
mented cytotoxicity in PA14 (Fig. 7B). Western immunoblot-
ting revealed that MgtE-N-His, MgtE-BS2/3, and MgtE-C-His
were expressed in the membrane of the P. aeruginosa mgtE
strain (Fig. 7C). Each of these constructs was detected as a
faint doublet on the blot. The faint band intensity has been
replicated several times, suggesting that MgtE might be a low-
abundance protein in the membrane of P. aeruginosa. The
results of these experiments demonstrate that we could sepa-
rate magnesium transport and regulation of cytotoxicity by
changing just three amino acids.
DISCUSSION
In this study, we have demonstrated that expression of MgtE
downregulates T3SS gene expression in P. aeruginosa. T3SS is
a potent virulence factor responsible for epithelial cell damage
in a number of different disease states. Modulation of T3SS
activity could potentially mitigate host damage during infec-
tion, and MgtE may be one factor modulating activity of this
virulence system. Our observation that deletion of mgtE results
in greater secretion of T3SS exoproteins suggests that P.
aeruginosa utilizes MgtE to carry out such modulation (Fig.
1A). In fact, we found that transformation of the wild-type
strain with pmgtE led to decreased cytotoxicity toward cultured
epithelial cells (Fig. 1B) and decreased transcription of T3SS
genes (Fig. 1C). Moreover, deletion of mgtE led to an increase
in cytotoxicity and T3SS transcription (Fig. 2 and 4). While
these changes were small, it has been shown previously that
small increases in ExoU secretion lead to large changes in
cytotoxicity (11, 31). Thus, adjusting the level of MgtE expres-
sion or activity during an infection might impact the ability of
P. aeruginosa to secrete T3SS toxins. In support of this hypoth-
esis, we previously found that tobramycin treatment of P.
aeruginosa biofilms on CFBE cells led to upregulation of mgtE
expression but downregulation of several T3SS genes (1). Un-
expectedly, we found that mgtE expression in exsE and exsE
exsD strains inhibited T3SS transcription to a greater extent
than mgtE expression in the wild type (Fig. 1C and 4). We do
not fully understand the basis of this effect although we spec-
ulate that it might be the result of competition between MgtE
and the intact T3SS regulatory network in the wild type.
It is interesting that mgtE mutation and expression affected
T3SS activity in biofilms as well as in the planktonic state. T3SS
transcriptional activation can be stimulated by decreasing cal-
cium concentration and by eukaryotic cell contact, such as
might be found during coculture biofilm formation (51). Our
data show that MgtE can affect T3SS under both conditions
FIG. 6. Magnesium transport and cytotoxicity can be separated. (A) Growth of S. Typhimurium MM281 on N minimal agar plates. MM281 was
complemented with vector control (p70), pmgtE, and plasmids pCHIS and pNHIS. (B) Cytotoxicity at 6 h of strain PA14 and the isogenic mgtE
deletion mutant complemented with the plasmids in panel A. A value of 100% cytotoxicity represents a maximum release from the CFBE cells
by Triton X-100 lysis. *, P 	 0.05, compared to mgtE p70.
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(Fig. 1 and S2). As mentioned above, recent studies have
suggested that T3SS expression is decreased in P. aeruginosa
biofilms compared to planktonic bacteria (13, 15). However, in
a previous study, we demonstrated that T3SS is expressed in
the coculture biofilm because deletion of the T3SS secretion
apparatus reduced cytotoxicity of the biofilm (1, 26). While it is
currently unknown how basal T3SS expression levels in cocul-
ture biofilms compare to levels in planktonic bacteria, it is clear
that T3SS expression in coculture biofilms can be affected by
MgtE levels in a manner similar to planktonic bacteria.
There are a number of different regulators that alter T3SS
transcription in P. aeruginosa although the ExsE-D-C-A cas-
cade appears to be the major regulatory system (51). Further-
more, all known T3SS regulators studied to date exert their
effects on ExsA (51). We have also found that the increased
cytotoxicity of our mgtE mutant requires exsA-mediated gene
transcription (Fig. 3). Our observation that mgtE expression in
the exsE exsD double mutant strain abrogated cytotoxicity
and gene expression (Fig. 4) indicates that MgtE exerts its
effects on the T3SS by either directly or indirectly impacting
the activity of ExsA. Our data reflect multiple experimental
replicates performed in two different P. aeruginosa strains,
suggesting a specific effect of MgtE on T3SS rather than ran-
dom metabolic fluctuations.
Other T3SS regulators also impact the activity of ExsA. For
instance, the copper-regulated inhibitor PtrA behaves similarly
to MgtE. Deletion of ptrA led to increased secretion of T3SS
exoproteins, and overexpression of ptrA decreased T3SS gene
transcription (17). It was also found that PtrA physically inter-
acts with ExsA and thus acts as an antiactivator, sequestering
ExsA to prevent T3SS transcription (17). Due to the similarity
in phenotypes between PtrA and MgtE, it seems possible that
MgtE might also be binding to ExsA to inhibit T3SS gene
transcription. Alternatively, mgtE expression might lead to the
upregulation of another factor that binds directly to ExsA.
Future studies will be aimed at investigating the molecular
mechanisms of MgtE-mediated T3SS inhibition in more detail.
One of the key findings of this report is that the mgtE gene
in P. aeruginosa encodes a magnesium transporter. While
members of the MgtE family of magnesium transporters have
been studied in many different organisms (including humans),
to our knowledge the P. aeruginosa mgtE homologue has never
been characterized (23, 30, 40). It is unknown whether P.
aeruginosa MgtE can transport calcium although calcium trans-
port through MgtE would be intriguing, considering the effect
of calcium on T3SS. While MgtE proteins from B. firmus and
Providencia stuartii have been shown to transport magnesium
and cobalt, they are not predicted to transport calcium (47, 49).
Moreover, it has been shown that mammalian homologues of
MgtE cannot transport calcium although these proteins can
transport many other cations (23, 30, 40). Our data demon-
strate that expression of P. aeruginosa mgtE can support mag-
nesium transport (Fig. 6A) and that the protein product is
present in the membrane (Fig. 7C).
On the other hand, we found that magnesium transport is
not necessary for inhibition of cytotoxicity (Fig. 6 and 7). By
FIG. 7. Point mutations in the magnesium binding sites of MgtE disrupt magnesium transport but not cytotoxicity. (A) Growth of S.
Typhimurium MM281 complemented with vector control (p70), mgtE plasmid (pmgtE), or the mgtE plasmid containing point mutations in
magnesium binding sites 2 and 3 (pBS2/3). Strains were grown overnight on N minimal medium agar plates. (B) Cytotoxicity at 6 h of PA14 and
the mgtE deletion mutant complemented with the plasmids in panel A. A value of 100% cytotoxicity represents a maximum release from the CFBE
cells by Triton X-100 lysis. *, P 	 0.05, compared to mgtE p70. (C) Western blot of total membrane fractions (left side) and cytoplasmic fractions
(right side) from mgtE transformed with vector control (p70), pNHIS, pBS2/3, and pCHIS. Fractions were incubated with anti-six-histidine (HIS)
primary antibodies as well as anti-SadB or anti-SecY primary antibodies to detect cytoplasmic and membrane control proteins, respectively. The
presence of the lower, nonspecific bands in SadB lanes (marked by an asterisk) has been noted previously (5). Apparent cytoplasmic presence of
SecY has also been previously reported (34). Importantly, there appears to be no cytoplasmic contamination of the membrane fraction.
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making three point mutations in putative magnesium binding
sites, we have disrupted the ability of MgtE to transport mag-
nesium (Fig. 7A). Structural analysis of MgtE under high-
magnesium concentrations has identified at least six sites at
which magnesium binds to MgtE under these conditions, thus
holding the pore in a closed conformation (18). Further com-
puter modeling has suggested a mechanism whereby sequential
binding of magnesium to these sites leads to proper closing of
the magnesium pore (20). By mutating two of these sites, we
have potentially altered the ability of the protein to transition
between open and closed conformations. However, these ac-
tions do not appear to be necessary for inhibition of cytotox-
icity because our binding site 2/3 mutant can fully complement
the mgtE mutant for its cytotoxicity phenotype (Fig. 7B). Our
results with this binding site mutant suggest that inhibition of
cytotoxicity is effected by some part of the MgtE structure
rather than the act of transporting magnesium or switching
between open and closed conformations. Recent studies of
the CorA magnesium transporter in S. Typhimurium (strain
SL1344) have reached a similar conclusion; CorA affected vir-
ulence despite inhibition of magnesium transport through the
protein (37).
The data presented in this study suggest the hypothesis that
P. aeruginosa has evolved dual functions for MgtE: magnesium
transport and virulence regulation. While these activities ap-
pear to be independent from one another, it is still formally
possible that magnesium can stimulate transcription of mgtE in
P. aeruginosa, as is the case in other organisms (10). Indeed, a
recent study found that mgtE transcription in P. aeruginosa can
be activated by limiting magnesium concentrations and that
this effect requires the magnesium-sensitive response regulator
PmrA (32). Thus, changes in magnesium concentration might
influence mgtE expression through PmrA and, thus, T3SS tran-
scription. However, magnesium must exert additional effects
on T3SS because magnesium treatment led to increased tran-
scription in the absence of mgtE as well (Fig. 2B). One possible
explanation comes from recent studies showing (i) that mag-
nesium treatment can alter P. aeruginosa lipopolysaccharide
structure and (ii) that alterations in lipopolysaccharide (LPS)
can lead to changes in T3SS activity (2, 16). It will be interest-
ing to investigate the potential role of magnesium in regulating
bacterial toxicity.
It is likely that MgtE is only one part of an interconnected
network of regulators involved in modulating cytotoxicity. Fu-
ture studies will focus on determining the relationship between
MgtE and other virulence-regulatory molecules.
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